Daclatasvir Nitroso
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Daclatasvir is used along with another medication (sofosbuvir [Solvadi]) to treat a certain type of chronic hepatitis C (an ongoing viral infection that damages the liver). Daclatasvir is in a class of antiviral medications called hepatitis C virus (HCV) NS5A inhibitors.Daclatasvir Nitroso is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Daclatasvir Nitroso CAS NO:NA chemically represented as Methyl ((S)-1-((S)-2-(5-(4'-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)-[1,1'-biphenyl]-4-yl)-1-nitroso-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate. Synchemia is the leading manufacturing and exporter of Daclatasvir Nitroso . We supply Daclatasvir Nitroso with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143889 |
| CAS No | NA |
| Mol.F. | C20H32N8O3S4 |
| Mol.Wt. | 560.77 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143890 |
| CAS No | NA |
| Mol.F. | C11H19N5O2S2 |
| Mol.Wt. | 317.43 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143891 |
| CAS No | NA |
| Mol.F. | C5H8N4O2S |
| Mol.Wt. | 188.21g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143892 |
| CAS No | NA |
| Mol.F. | C12H20N6O4S2 |
| Mol.Wt. | 376. 45 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143893 |
| CAS No | NA |
| Mol.F. | C12H17N5O3S3 |
| Mol.Wt. | 375.48 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143894 |
| CAS No | NA |
| Mol.F. | C12H17D3N6O3S2 |
| Mol.Wt. | 363.47g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143895 |
| CAS No | NA |
| Mol.F. | C23H21D6ClN8O5S |
| Mol.Wt. | 569.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143896 |
| CAS No | NA |
| Mol.F. | C24H29ClN8O5S |
| Mol.Wt. | 577.11 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143897 |
| CAS No | NA |
| Mol.F. | C24H29ClN8O5S |
| Mol.Wt. | 577.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143898 |
| CAS No | NA |
| Mol.F. | C24H29ClN8O5S |
| Mol.Wt. | 577.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143899 |
| CAS No | NA |
| Mol.F. | C8H8N2O3S |
| Mol.Wt. | 212.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143900 |
| CAS No | NA |
| Mol.F. | C7H7BrN2OS |
| Mol.Wt. | 247.11 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143901 |
| CAS No | NA |
| Mol.F. | C9H11N3O3S |
| Mol.Wt. | 241.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143902 |
| CAS No | NA |
| Mol.F. | C14H24N6O7 |
| Mol.Wt. | 340.38 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143903 |
| CAS No | NA |
| Mol.F. | C14H25N3O5 |
| Mol.Wt. | 315.37 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143904 |
| CAS No | NA |
| Mol.F. | C15H27N3O7S |
| Mol.Wt. | 393.46 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |